COMMUNIQUÉS West-GlobeNewswire

Obalon to Host Call to Provide Update on Commercial Strategy Post FDA Approval of the Obalon Navigation System
02/01/2019
SAN DIEGO, Jan. 02, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric [...]
Innovation Pharmaceuticals Receives New Brilacidin Patent, Further Expanding Intellectual Property Estate
02/01/2019
BEVERLY, Mass., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage pharmaceutical company, reported today that the U.S. Patent & Trademark Office recently [...]
Oxford Immunotec to Present at the 37th Annual J.P. Morgan Healthcare Conference
02/01/2019
OXFORD, United Kingdom and MARLBOROUGH, Mass., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that Dr. Peter Wrighton-Smith, Chief [...]
Obalon Announces Promotion of Kelly Huang, Ph.D. To Chief Executive Officer
02/01/2019
SAN DIEGO, Jan. 02, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric [...]
Acer Therapeutics Announces In-license of Osanetant from Sanofi
02/01/2019
Acer acquires worldwide rights to clinical-stage NK3 receptor antagonist NEWTON, Mass., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, [...]
Align Technology to Announce Fourth Quarter and 2018 Results on January 29, 2019
02/01/2019
SAN JOSE, Calif., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN) announced today that the Company will report fourth quarter and 2018 financial results on Tuesday, January 29, 2019 after the [...]
Hemispherx Biopharma Inc. Announces Advancement in Expanded Access Program for Ampligen in the Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
02/01/2019
Second Large Shipment Dispatched to Second Major Clinic OCALA, Fla., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB), an immuno-pharma R&D and emerging commercial growth company [...]
AIT Strengthens Executive Leadership Team with Appointment of Chief Commercial Officer
02/01/2019
Former Worldwide Vice President at Becton Dickinson (BD), Duncan Fatkin, Appointed AIT’s Chief Commercial Officer GARDEN CITY, N.Y. and REHOVOT, Israel, Jan. 02, 2019 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (OTCQB: [...]
Progenics Pharmaceuticals Expands Leadership Team with Appointment of Asha Das, M.D. as Chief Medical Officer
02/01/2019
NEW YORK, Jan. 02, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), an oncology company developing innovative medicines and imaging analysis technology for targeting and treating cancer, today [...]
Teligent, Inc. Announces FDA Approval of Gentamicin Sulfate Ointment USP, 0.1%
02/01/2019
BUENA, N.J., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug [...]
Sarepta Therapeutics Enters into Long-term Strategic Relationship with Aldevron for GMP-grade Plasmid in Support of Gene Therapy Development and Commercial Manufacturing Strategy
02/01/2019
-- Agreement provides Sarepta with committed capacity and dedicated manufacturing slots for GMP-grade plasmid production for its micro-dystrophin Duchenne muscular dystrophy (DMD) gene therapy program, as well as [...]
ChemoCentryx to Present at the 37th Annual J.P. Morgan Healthcare Conference
02/01/2019
MOUNTAIN VIEW, Calif., Jan. 02, 2019 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will present at the 37th Annual J.P. [...]
Nuvectra Announces Divesture of NeuroNexus Subsidiary
02/01/2019
PLANO, Texas, Jan. 02, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it has entered into an agreement effective December 31, 2018, to sell [...]
Editas Medicine to Present at the 37th Annual J.P. Morgan Healthcare Conference
02/01/2019
CAMBRIDGE, Mass., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that it will present a company overview followed by a question and answer [...]
Aptinyx to Present at 37th Annual J.P. Morgan Healthcare Conference
02/01/2019
EVANSTON, Ill., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (NASDAQ: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, [...]
Auransa to Present at Biotech Showcase 2019
02/01/2019
PALO ALTO, Calif., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Auransa Inc., an artificial intelligence (AI)-driven biotechnology company developing precision medicines in areas of significant unmet medical need, today announced [...]
Leading BioSciences to Present at Biotech Showcase 2019
02/01/2019
CARLSBAD, Ca., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Leading BioSciences, a drug development company focused on improving human health through therapeutic protection of the Gastrobiome ™ , today announced that its chief [...]
Allscripts closes previously announced sale of its interests in Netsmart
02/01/2019
CHICAGO, Jan. 02, 2019 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX) closed the previously announced sale of its interests in Netsmart Technologies, Inc. on December 31, 2018. Additional pro forma financial details [...]
Mersana Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference
02/01/2019
CAMBRIDGE, Mass., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs [...]

Pages